Deep Dive: Market Access – Breaking Barriers

In this issue of Deep Dive we look at the changing landscape for pharma market access and start to assess the impact of the COVID-19 pandemic.

Deep Dive: Market Access – Breaking Barriers also explores the market access challenges that will remain during and after the coronavirus crisis – including biosimilar market access, how R&D processes affect pricing and reimbursement, and how pharma can work with payers to make sure as many patients as possible get access to drugs.